Colchicine reduces the risk of major cardiovascular events in patients with chronic coronary disease, according to results of the LoDoCo2 trial presented in a Hot Line session today at ESC Congress 2020.
Aug 31, 2020
0
5
Depression or anxiety in adolescence is linked with a 20% greater likelihood of having a heart attack mid-life, according to research released today at ESC Congress 2020.
Aug 26, 2020
0
4
A study of search engine queries addressed the question of whether online searches for chest pain symptoms correlated to reports of fewer people going to the emergency department with acute heart problems during the COVID-19 ...
Aug 25, 2020
0
2
Researchers found a striking association between BMI and risk for death among patients with a diagnosis of COVID-19. The association was independent of obesity-related comorbities and other potential confounders. Their findings ...
Aug 14, 2020
1
37
A single intravenous dose of MRG-110, an anti-microRNA drug, significantly reduced miR-92a levels in the blood of healthy humans. Inhibition of miR-92a has shown beneficial effects in animal models, including improved vascularization ...
Aug 12, 2020
0
1
In a study published today in the Journal of the American College of Cardiology of more than 5,000 acute coronary syndromes (ACS) patients, 71.8% were considered malnourished by at least one nutrition screening test, and ...
Aug 10, 2020
0
0
(HealthDay)—During the early COVID-19 period, there was a decrease in hospitalization rates for acute myocardial infarction (AMI), according to a brief report published online Aug. 7 in JAMA Cardiology.
Aug 10, 2020
0
1
A study recently published in the journal Circulation looks at temporal trends in the burden of comorbidities and associated risk of mortality among patients with heart failure (HF) with preserved ejection fraction (HFpEF), ...
Jul 30, 2020
0
4
In the first study to examine the association between high out-of-pocket costs and adverse cardiovascular events, research led by the Harvard Pilgrim Health Care Institute finds that individuals with cardiovascular disease ...
Jul 24, 2020
0
1
(HealthDay)—For elderly or low-weight patients with acute coronary syndrome (ACS), a reduced dose of prasugrel is efficacious compared with ticagrelor, according to a study published online July 21 in the Annals of Internal ...
Jul 21, 2020
0
2
